Marine Prods (NYSE:MPX) Bolsa

Marine Prods

Marine Products Corp is a manufacturer of fiberglass motorized boats distributed and marketed through its independent dealer network. The company's only operating segment is Powerboat Manufacturing Business. It operates in the Powerboat Manufacturing business segment through Nashville, Georgia, Valdosta, and Georgia. Its product offerings include Chaparral sterndrive, outboard pleasure boats and Robalo outboard sport fishing boats. The company offers its products to the family recreational markets through its Chaparral brand and to the sportfishing market through its Robalo brand.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ANAB

ASST

CCLD

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

DWTX

HSDT

HUBC

LSTA

NEHC

NFLX

SEPN

STFS

USEG

Netflix sorprende con un aumento en suscriptores y mejores pronósticos. Descubre también los mayores ganadores y perdedores del premercado.

Acciones de Netflix se disparan alrededor del 15%; 20 acciones que se están moviendo en el premercado de EE.UU.

Marine Products Corp

MPX INTL CORP by MPX International Corporation

MPX International Corp

General

Marine Products shares are trading lower. The company reported Q4 financial results

Marine Prods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPX#NYSE">MPX</a>) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.05 by 140 percent. This is a 25 percent decrease over earnings of $0.16 per share from the same period last year. The company reported quarterly sales of $47.82 million which beat the analyst consensus estimate of $46.30 million by 3.28 percent. This is a 32.53 percent decrease over sales of $70.87 million the same period last year.

Earnings

Earnings Beats

Marine Prods Q4 EPS $0.12 Beats $0.05 Estimate, Sales $47.82M Beat $46.30M Estimate

AAPL

ABCB

ALGM

APPF

Adtalem Global Education Inc. Common Stock

ATGE

BAFN

BBVA

BHLB

BOOT

CACC

CHKP

CIVB

CMCSA

CNOB

COUR

CSWI

CVCO

DECK

FBIZ

FCFS

FFWM

FINW

FISI

FLWS

FRME

GSIT

INTC

KLAC

KRNY

LPLA

MBLY

MBUU

NTCT

ONEW

PFSI

REAL

SCSC

SHEL

SILC

SIRI

SKYW

STBA

STEL

Earnings Scheduled For January 30, 2025

U.S. stock futures were higher this morning, with the Nasdaq futures gaining over 150 points on Wednesday.
Shares of Progress Software Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRGS#NASDAQ">PRGS</a>) fell sharply in today's pre-market trading after the company issued first-quarter EPS <a href="https://www.benzinga.com/quote/PRGS/earnings">guidance below estimates</a>.
Progress Software reported quarterly earnings of $1.33 per share which beat the analyst consensus estimate of $1.22 per share. The company reported quarterly sales of $215.00 million which beat the analyst consensus estimate of $211.25 million.
Progress Software said it sees first-quarter revenue of $232 million to $238 million versus market estimates of $235.840 million. The company projects adjusted earnings of $1.02 to $1.08 per share, versus expectations of $1.25 per share.
Progress Software shares declined 2.6% to $61.90 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Associated Capital Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AC#NYSE">AC</a>) fell 43.7% to $20.00 in pre-market trading. Associated Capital recently reported estimated fourth quarter and full year results</li>
<li>Septerna, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEPN#NASDAQ">SEPN</a>) fell 14.4% to $16.01 in pre-market trading after gaining more than 10% on Tuesday.</li>
<li>AnaptysBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANAB#NASDAQ">ANAB</a>) declined 12.3% to $14.81 in pre-market trading after gaining over 6% on Tuesday.</li>
<li>Marine Products Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPX#NYSE">MPX</a>) dipped 11.3% to $8.04 in pre-market trading. Marine Products will release its financial results for the fourth quarter on Thursday, Jan. 30, before the market opens.</li>
<li>Zenas BioPharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBIO#NASDAQ">ZBIO</a>) shares fell 8.2% to $7.71 in pre-market trading.</li>
<li>GH Research PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GHRS#NASDAQ">GHRS</a>) dipped 7.7% to $8.30 in pre-market trading.</li>
<li>Dogness (International) Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOGZ#NASDAQ">DOGZ</a>) fell 4.5% to $27.47 in pre-market trading.</li>
<li>Disc Medicine, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRON#NASDAQ">IRON</a>) fell 2.7% to $58.88 in pre-market trading as the company announced a proposed $200 million public offering of common stock and pre-funded warrants.</li>
</ul>
Now Read This:
<ul>
<li> <a href="https://www.benzinga.com/25/01/43096091/jim-cramer-this-tech-stock-is-a-buy-louisiana-pacific-has-been-a-great-stock">Jim Cramer: This Tech Stock Is A Buy, Louisiana-Pacific Has Been A &#8216;Great Stock&#8217;</a></li>
</ul>

DOGZ

GHRS

IRON

PRGS

ZBIO

Progress Software, Disc Medicine And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Shares of Netflix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) rose sharply in today's pre-market trading as the company reported stronger-than-expected <a href="https://www.benzinga.com/news/earnings/25/01/43114866/netflix-q4-earnings-record-subscribers-nfl-squid-game-push-past-highest-expectations">fourth-quarter financial results</a>.
Netflix reported it added 18.91 million paid subscribers in the fiscal quarter, up 15.9% year-over-year. The company said it sees full-year revenue of $43.5 billion to $44.5 billion, up $0.5 billion from the company's previous range
Netflix shares jumped 14.6% to $996.60 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>ImmunoPrecise Antibodies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPA#NASDAQ">IPA</a>) gained 58.8% to $0.7833 in pre-market trading. ImmunoPrecise Antibodies recently launched its AI-powered pipeline of both optimized and new therapeutics.</li>
<li>New Era Helium, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEHC#NASDAQ">NEHC</a>) rose 42% to $3.89 in pre-market trading. New Era Helium recently announced a joint venture with Sharon AI to construct and develop a 250MW net-zero energy data center..</li>
<li>Cardio Diagnostics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDIO#NASDAQ">CDIO</a>) rose 40.2% to $0.8520 in pre-market trading after jumping around 15% on Tuesday.</li>
<li>Asset Entities Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASST#NASDAQ">ASST</a>) gained 25.7% to $1.13 in pre-market trading after jumping 94% on Tuesday.</li>
<li>U.S. Energy Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USEG#NASDAQ">USEG</a>) gained 21.5% to $4.61 in pre-market trading after surging 63% on Tuesday.</li>
<li>Metagenomi, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGX#NASDAQ">MGX</a>) gained 20.2% to $3.27 in pre-market trading following a 4% gain on Tuesday.</li>
<li>Tempus AI, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>) gained 14.7% to $54.65 in pre-market trading. Tempus AI shares jumped over 35% on Tuesday after Nancy Pelosi disclosed the purchase of 50 Jan 2026 call options.</li>
<li>CareCloud, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCLD#NASDAQ">CCLD</a>) gained 13.3% to $3.50 in pre-market trading after surging over 10% on Tuesday.</li>
<li>Sable Offshore Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOC#NYSE">SOC</a>) gained 13.2% to $29.63 in pre-market trading after gaining around 7% on Tuesday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Associated Capital Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AC#NYSE">AC</a>) fell 43.7% to $20.00 in pre-market trading. Associated Capital recently reported estimated fourth quarter and full year results</li>
<li>Star Fashion Culture Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STFS#NASDAQ">STFS</a>) shares fell 20.7% to $10.72 in pre-market trading after dipping around 9% on Tuesday.</li>
<li>HUB Cyber Security Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUBC#NASDAQ">HUBC</a>) fell 19.5% to $0.68 in pre-market trading after the company announced the receipt of a Staff Delisting Notice.</li>
<li>Lisata Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSTA#NASDAQ">LSTA</a>) shares dipped 17.4% to $3.22 in pre-market trading after gaining 5% on Tuesday.</li>
<li>Septerna, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEPN#NASDAQ">SEPN</a>) fell 14.4% to $16.01 in pre-market trading after gaining more than 10% on Tuesday.</li>
<li>Helius Medical Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSDT#NASDAQ">HSDT</a>) shares tumbled 13.1% to $0.8949 in pre-market trading after the company announced exercise of warrants and issuance of new warrants in a private placement for $3.7 million gross proceeds priced at-the-market.</li>
<li>Dogwood Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DWTX#NASDAQ">DWTX</a>) shares fell 13% to $2.74 in pre-market trading. Dogwood Therapeutics shares jumped 68% on Tuesday after the company announced patient dosing for its Phase 2b trial evaluating halneuron will commence in Q1 2025.</li>
<li>AnaptysBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANAB#NASDAQ">ANAB</a>) declined 12.3% to $14.81 in pre-market trading after gaining over 6% on Tuesday.</li>
<li>InMed Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INM#NASDAQ">INM</a>) fell 11.8% to $4.45 in today's pre-market trading. InMed Pharmaceuticals recently announced that INM-901 reduced Alzheimer &#8216;s-related inflammation in a preclinical study.</li>
<li>Marine Products Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPX#NYSE">MPX</a>) dipped 11.3% to $8.04 in pre-market trading. Marine Products will release its financial results for the fourth quarter on Thursday, Jan. 30, before the market opens.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43096091/jim-cramer-this-tech-stock-is-a-buy-louisiana-pacific-has-been-a-great-stock">Jim Cramer: This Tech Stock Is A Buy, Louisiana-Pacific Has Been A &#8216;Great Stock&#8217;</a></li>
</ul>

Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

WIIM

ABNB

AENT

AGAE

ARMK

BALY

CENN

DENN

EXPE

FEBO

FIGS

FNKO

GMBL

GOLF

GORV

JZXN

LAUR

LAZR

LIND

LOBO

MGOL

MOND

NCLH

PATK

PENN

PRKS

PTON

SERV

SGHC

SPGC

TDUP

UXIN

WOOF

XPOF

Shares of companies within the broader consumer discretionary sector are trading higher. Investors may be reacting to the US presidential election and its impact on consumer spending.

Marine Prods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPX#NYSE">MPX</a>) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.08 by 25 percent. This is a 66.67 percent decrease over earnings of $0.30 per share from the same period last year. The company reported quarterly sales of $49.85 million which missed the analyst consensus estimate of $50.97 million by 2.20 percent. This is a 35.91 percent decrease over sales of $77.79 million the same period last year.

Earnings Misses

Marine Prods Q3 EPS $0.10 Beats $0.08 Estimate, Sales $49.85M Miss $50.97M Estimate

Marine Prods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPX#NYSE">MPX</a>) is gearing up to announce its quarterly earnings on Thursday, 2024-10-24. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Marine Prods will report an earnings per share (EPS) of $0.08.
The market awaits Marine Prods's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Earnings Track Record</h3>
In the previous earnings release, the company missed EPS by $0.00, leading to a 2.01% increase in the share price the following trading session.
Here's a look at Marine Prods's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.14</td>
<td></td>
<td>0.19</td>
<td>0.36</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.14</td>
<td>0.13</td>
<td>0.16</td>
<td>0.30</td>
</tr>
<tr>
<td>Price Change %</td>
<td>2.0%</td>
<td>2.0%</td>
<td>1.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<h3>Tracking Marine Prods's Stock Performance</h3>
Shares of Marine Prods were trading at $9.38 as of October 22. Over the last 52-week period, shares are down 16.97%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<a href="https://www.benzinga.com/quote/MPX/earnings">To track all earnings releases for Marine Prods visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Examining the Future: Marine Prods's Earnings Outlook

DA Davidson analyst Brandon Rolle maintains Marine Prods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPX#NYSE">MPX</a>) with a Neutral and lowers the price target from $11 to $8.

Price Target

Analyst Ratings

DA Davidson Maintains Neutral on Marine Prods, Lowers Price Target to $8

Marine Prods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPX#NYSE">MPX</a>) reported quarterly earnings of $0.14 per share which met the analyst consensus estimate. This is a 66.67 percent decrease over earnings of $0.42 per share from the same period last year. The company reported quarterly sales of $69.55 million which beat the analyst consensus estimate of $65.35 million by 6.42 percent. This is a 40.13 percent decrease over sales of $116.16 million the same period last year.

Marine Prods Q2 EPS $0.14, Inline, Sales $69.55M Beat $65.35M Estimate

<h3>Gainers</h3>
<ul>
<li>Visionary Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GV#NASDAQ">GV</a>) shares moved upwards by 35.3% to $0.4 during Thursday's regular session. The company's market cap stands at $20.4 million. </li>
<li>Fitell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) stock increased by 29.2% to $14.6. The market value of their outstanding shares is at $293.5 million. </li>
<li>PlayAGS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGS#NYSE">AGS</a>) stock moved upwards by 28.01% to $11.47. The company's market cap stands at $461.1 million. As per the press release, Q1 earnings came out today. </li>
<li>Noodles (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDLS#NASDAQ">NDLS</a>) shares moved upwards by 21.96% to $2.11. The market value of their outstanding shares is at $95.6 million. The company's, Q1 earnings came out yesterday. </li>
<li>ATRenew (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NYSE">RERE</a>) shares increased by 21.42% to $2.98. The company's market cap stands at $659.5 million. </li>
<li>Arhaus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARHS#NASDAQ">ARHS</a>) shares moved upwards by 17.7% to $15.56. The company's market cap stands at $2.1 billion. The company's, Q1 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Delta Apparel (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/DLA#AMEX">DLA</a>) shares decreased by 29.2% to $1.99 during Thursday's regular session. The company's market cap stands at $14.0 million. As per the press release, Q2 earnings came out yesterday. </li>
<li>Duolingo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUOL#NASDAQ">DUOL</a>) stock decreased by 18.03% to $200.55. The company's market cap stands at $8.6 billion. The company's, Q1 earnings came out yesterday. </li>
<li>Accel Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACEL#NYSE">ACEL</a>) stock fell 14.65% to $9.91. The market value of their outstanding shares is at $830.2 million. The company's, Q1 earnings came out yesterday. </li>
<li>NWTN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWTN#NASDAQ">NWTN</a>) shares decreased by 14.09% to $3.05. The company's market cap stands at $872.8 million. </li>
<li>Marine Prods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPX#NYSE">MPX</a>) shares decreased by 13.53% to $10.46. The market value of their outstanding shares is at $362.6 million. </li>
<li>Lanvin Group Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LANV#NYSE">LANV</a>) stock decreased by 12.99% to $1.4. The company's market cap stands at $164.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACEL

ARHS

DUOL

FTEL

LANV

NDLS

NWTN

RERE

12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session

Marine Prods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPX#NYSE">MPX</a>) reported quarterly earnings of $0.13 per share. This is a 61.76 percent decrease over earnings of $0.34 per share from the same period last year. The company reported $69.34 million in sales this quarter. This is a 41.69 percent decrease over sales of $118.91 million the same period last year.

Marine Prods Q1 EPS $0.13 Down From $0.34 YoY, Sales $69.34M Down From $118.91M YoY

<h3>What Defines a Value Stock?</h3>
A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued. 
<h2>Below is a list of notable value stocks in the consumer cyclical sector:</h2>
<ol>
<li>eBay (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NASDAQ">EBAY</a>) - P/E: 8.73</li>
<li>Marine Prods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPX#NYSE">MPX</a>) - P/E: 8.79</li>
<li>Aptiv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APTV#NYSE">APTV</a>) - P/E: 7.6</li>
<li>Virco Mfg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRC#NASDAQ">VIRC</a>) - P/E: 5.32</li>
<li>Hibbett (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIBB#NASDAQ">HIBB</a>) - P/E: 8.61</li>
</ol>
eBay has been featured as a value stock. eBay's Q3 EPS sits at $1.03, which has not changed since last quarter (Q2). The company's most recent dividend yield sits at 2.56%, which has increased by 0.49% from 2.07% last quarter. 
Marine Prods's earnings per share for Q4 sits at $0.16, whereas in Q3, they were at 0.3. Its most recent dividend yield is at 5.07%, which has increased by 0.81% from 4.26% in the previous quarter.
Aptiv saw an increase in earnings per share from 1.3 in Q3 to $1.4 now. Its most recent dividend yield is at 0.97%, which has decreased by 0.01% from 0.98% in the previous quarter.
Virco Mfg's earnings per share for Q3 sits at $0.62, whereas in Q2, they were at 0.95. Its most recent dividend yield is at 1.4%, which has decreased by 0.06% from 1.46% in the previous quarter.
Hibbett's earnings per share for Q3 sits at $2.05, whereas in Q2, they were at 0.85. Its most recent dividend yield is at 1.87%, which has decreased by 0.48% from 2.35% in the previous quarter.
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.

APTV

EBAY

HIBB

VIRC

A Look Into Consumer Cyclical Sector Value Stocks

DOOO

ECDA

FFIE

IRBT

KXIN

LESL

LGIH

MODG

NRDY

PLBY

POOL

SLDP

SLNA

SNPO

TMHC

UCAR

ZCMD

Shares of several companies in the broader consumer discretionary sector are trading lower after January CPI data showed a greater-than-expected rise in inflation.

Shares of Humana Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hum#NYSE">HUM</a>) fell sharply during Thursday&rsquo;s session after the company reported fourth-quarter FY23 earnings and issued 2024 guidance.
The company reported a Q4 adjusted loss of 11 cents per share, a turnaround from EPS income of $1.97 per share a year ago, missing the consensus for a loss of 5 cents per share. The insurer reported adjusted revenue of $25.73 billion, compared to $21.30 billion a year ago and the consensus of $25.55 billion.
Humana shares dipped 11.3% to $356.93 on Thursday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Onconetix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/onco#NASDAQ">ONCO</a>) shares surged 137% to $0.3519 after falling over 4% on Wednesday.</li>
<li>Processa Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pcsa#NASDAQ">PCSA</a>) gained 97% to $4.0527 after the company announced the completion of the safety tolerability evaluation in its Phase 1b trial of Next Generation Capecitabine.</li>
<li>Enviva Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eva#NYSE">EVA</a>) climbed 47.4% to $0.5239.</li>
<li>Vera Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vera#NASDAQ">VERA</a>) shares jumped 46% to $24.84 after the company announced 72-week data from the OLE period of its Phase 2b ORIGIN clinical trial. Also, Oppenheimer initiated coverage on the stock with an Outperform rating and announced a $26 price target.</li>
<li>Rail Vision Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvsn#NASDAQ">RVSN</a>) gained 43.8% to $7.78. Foresight&#39;s affiliate Rail Vision&#39;s Main Line System secured EU Railway Standards approval and certifications.</li>
<li>LAVA Therapeutics N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lvtx#NASDAQ">LVTX</a>) rose 37.4% to $2.13 after the company announced a clinical trial collaboration and supply agreement with Merck &amp; Co. to evaluate LAVA-1207 in combination with KEYTRUDA.</li>
<li>Acutus Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/afib#NASDAQ">AFIB</a>) shares climbed 30.6% to $0.29. Acutus Medical has been granted European patent number EP3043701 titled &quot;Devices and Methods for Determination of Electrical Dipole Densities on a Cardiac Surface (And Methods for Diagnosing Tissue Health).&quot;</li>
<li>Prairie Operating Co. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prop#NASDAQ">PROP</a>) gained 28.8% to $8.17.</li>
<li>American Superconductor Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amsc#NASDAQ">AMSC</a>) shares climbed 28.4% to $12.52 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter revenue guidance above estimates.</li>
<li>CCSC Technology International Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cctg#NASDAQ">CCTG</a>) rose 26.6% to $18.82.</li>
<li>Clearmind Medicine Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmnd#NASDAQ">CMND</a>) gained 25.8% to $1.4601.</li>
<li>Cyngn Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cyn#NASDAQ">CYN</a>) gained 23.3% to $0.2256 after the company disclosed a strategic shift to Nvidia AI computers that will transform the technology powering its fleet of DriveMod autonomous industrial vehicles.</li>
<li>Richtech Robotics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rr#NASDAQ">RR</a>) rose 21.3% to $9.10. Richtech Robotics signed a Letter of Intent with Ghost Kitchens International.</li>
<li>AlTi Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alti#NASDAQ">ALTI</a>) surged 20.8% to $6.82 after Raymond James upgraded the stock from Market Perform to Strong Buy and announced a $9 price target.</li>
<li>C3is Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ciss#NASDAQ">CISS</a>) jumped 19.1% to $0.1579. Aegis Capital Corp. acted as sole bookrunner on an upsized $7.0 million underwritten public offering for C3is.</li>
<li>Hut 8 Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hut#NASDAQ">HUT</a>) climbed 14.7% to $7.28.</li>
<li>Charge Enterprises, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crge#NASDAQ">CRGE</a>) rose 13.6% to $0.1672 following a 6% decline on Wednesday.</li>
<li>Biomea Fusion, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bmea#NASDAQ">BMEA</a>) gained 12.8% to $16.92</li>
<li>United Rentals, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uri#NYSE">URI</a>) gained 12.7% to $649.95 after the company reported better-than-expected fourth-quarter financial results and issued FY24 revenue guidance.</li>
<li>Alpine Immune Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alpn#NASDAQ">ALPN</a>) jumped 12.4% to $20.88</li>
<li>Nokia Oyj (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nok#NYSE">NOK</a>) gained 12.3% to $3.8299 after the company reported fourth-quarter financial results.</li>
<li>Xerox Holdings Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xrx#NYSE">XRX</a>) gained 12.3% to $18.47 following quarterly results.</li>
<li>ADT Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/adt#NYSE">ADT</a>) gained 10.2% to $6.81 after the company announced it will exit its residential solar business. The company also said it would increase its dividend and authorize a $350 million share repurchase program.</li>
<li>International Business Machines Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ibm#NYSE">IBM</a>) shares gained 9.9% to $191.19 as the company reported reported stronger-than-expected results for its fourth quarter.</li>
<li>American Airlines Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aal#NASDAQ">AAL</a>) jumped 9.6% to $15.27 after the company reported better-than-expected fourth-quarter results.</li>
<li>NextEra Energy Partners, LP (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nep#NYSE">NEP</a>) climbed 9.3% to $29.35 after the company reported quarterly financial results.</li>
<li>W. R. Berkley Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wrb#NYSE">WRB</a>) gained 7.2% to $83.30 after the company reported better-than-expected quarterly financial results.</li>
<li>TAL Education Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tal#NYSE">TAL</a>) gained 6.5% to $12.03 following a third-quarter revenue beat. Additionally, JP Morgan upgraded the stock to Overweight.</li>
<li>Alaska Air Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/alk#NYSE">ALK</a>) rose 5.1% to $37.63 following upbeat earnings.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>RedHill Biopharma Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdhl#NASDAQ">RDHL</a>) shares dropped 44.4% to $0.6009 after the company announced an $8 million registered direct offering.</li>
<li>VS MEDIA Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vsme#NASDAQ">VSME</a>) shares fell 22.1% to $0.5049 after jumping around 98% on Wednesday.</li>
<li>Columbia Banking System, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/colb#NASDAQ">COLB</a>) fell 21.9% to $19.98 after the company reported worse-than-expected fourth-quarter financial results.</li>
<li>Polished.com Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pol#NYSE">POL</a>) fell 21.8% to $3.71.</li>
<li>Akoustis Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akts#NASDAQ">AKTS</a>) shares fell 21.8% to $0.5508 after the company announced pricing of a public offering of $10 million of common stock.</li>
<li>MarineMax, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hzo#NYSE">HZO</a>) dipped 19.9% to $26.61 after the company reported worse-than-expected first-quarter adjusted EPS results and issued FY24 adjusted EPS guidance below estimates.</li>
<li>Marpai, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrai#NASDAQ">MRAI</a>) fell 17.3% to $1.43.</li>
<li>Inseego Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/insg#NASDAQ">INSG</a>) fell 16.6% to $2.0362.</li>
<li>Concentrix Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnxc#NASDAQ">CNXC</a>) fell 16.2% to $87.10 after the company issued first-quarter and FY24 guidance below consensus estimates.</li>
<li>Immix Biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/immx#NASDAQ">IMMX</a>) declined 16.2% to $3.92.</li>
<li>Tesla, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsla#NASDAQ">TSLA</a>) shares fell 13.1% to $180.61 after the company reported downbeat earnings and sales results for its fourth quarter.</li>
<li>Rackspace Technology, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rxt#NYSE">RXT</a>) fell 12.8% to $1.6750.</li>
<li>ESSA Pharma Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/epix#NASDAQ">EPIX</a>) fell 11.2% to $7.81. ESSA Pharma presented updated Phase 1 masofaniten clinical data at the 2024 ASCO Genitourinary Cancers Symposium.</li>
<li>Phunware, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phun#NASDAQ">PHUN</a>) declined 11.1% to $0.3075 after dipping around 20% on Wednesday.</li>
<li>Virtu Financial, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/virt#NASDAQ">VIRT</a>) fell 9.6% to $17.35 after the company reported worse-than-expected fourth-quarter financial results.</li>
<li>Old Republic International Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ori#NYSE">ORI</a>) fell 9.6% to $27.43 as the company reported worse-than-expected fourth-quarter results.</li>
<li>Carpenter Technology Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crs#NYSE">CRS</a>) fell 7.4% to $61.08 following mixed quarterly earnings.</li>
<li>Marine Products Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mpx#NYSE">MPX</a>) declined 7% to $ 10.27 following fourth-quarter results.</li>
<li>ATI Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ati#NYSE">ATI</a>) fell 6.4% to $40.18.</li>
<li>Hexcel Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hxl#NYSE">HXL</a>) shares declined 6.4% to $66.98 after reporting weak quarterly results.</li>
<li>LG Display Co., Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lpl#NYSE">LPL</a>) shares fell 3% to $4.5250 after the company reported fourth-quarter financial results.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/01/36776429/jim-cramer-this-healthcare-stock-is-too-risky-but-shares-jumped-64-over-past-month"> Jim Cramer: This Healthcare Stock Is &#39;Too Risky,&#39; But Shares Jumped 64% Over Past Month </a>

Penny Stocks

Small Cap

Intraday Update

AFIB

AKTS

ALPN

ALTI

AMSC

BMEA

CCTG

CISS

CMND

CNXC

COLB

CRGE

EPIX

IMMX

INSG

LVTX

MRAI

ONCO

PCSA

PHUN

PROP

RDHL

RVSN

TSLA

VERA

VIRT

VSME

Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Comments

Marine Prods

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL